Weil; Tanja

Patent Applications and Registrations

Patent applications and USPTO patent grants for Weil; Tanja.The latest application filed is for "systems and methods for low pressure diamond growth without plasma including seeding growth".

Company Profile

3.10.19

Weil; Tanja - Mainz DE
Weil; Tanja - Frankfurt am Main DE
Weil; Tanja - Ulm DE
Weil; Tanja - Singapore SG
Weil; Tanja - Heidelberg DE
Weil; Tanja - Frankfurt/Main DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Systems And Methods For Low Pressure Diamond Growth Without Plasma Including Seeding Growth App 20220025544 - Hemmer; Philip R. ; et al.	2022-01-27
Carrier for targeting nerve cells Grant 10,883,096 - Rummel , et al. January 5, 2	2021-01-05
Carrier For Targeting Nerve Cells App 20200024588 - RUMMEL; Andreas ; et al.	2020-01-23
Carrier for targeting nerve cells Grant 10,266,816 - Rummel , et al.	2019-04-23
Carrier For Targeting Nerve Cells App 20170275607 - Rummel; Andreas ; et al.	2017-09-28
Carrier for targeting nerve cells Grant 9,650,622 - Rummel , et al. May 16, 2	2017-05-16
Carrier for targeting nerve cells Grant 9,115,350 - Rummel , et al. August 25, 2	2015-08-25
Carrier For Targeting Nerve Cells App 20150038401 - Rummel; Andreas ; et al.	2015-02-05
Carrier For Targeting Nerve Cells App 20130315888 - Rummel; Andreas ; et al.	2013-11-28
Carrier for targeting nerve cells Grant 8,481,040 - Rummel , et al. July 9, 2	2013-07-09
Metabotropic Glutamate Receptor Modulators App 20120178742 - Henrich; Markus ; et al.	2012-07-12
Pyrazolopyrimidines for treating CNS disorders App 20110212956 - Danysz; Wojciech ; et al.	2011-09-01
Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators Grant 7,985,753 - Danysz , et al. July 26, 2	2011-07-26
Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators Grant 7,947,689 - Danysz , et al. May 24, 2	2011-05-24
Pyrazolopyrimidines, A Process For Their Preparation And Their Use As Medicine App 20110003820 - Henrich; Markus ; et al.	2011-01-06
Carrier for targeting nerve cells App 20090311275 - Rummel; Andreas ; et al.	2009-12-17
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors Grant 7,598,384 - Jirgensons , et al. October 6, 2	2009-10-06
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors App 20090227582 - Kauss; Valerjans ; et al.	2009-09-10
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors Grant 7,550,482 - Kauss , et al. June 23, 2	2009-06-23
Pyrazolopyrimidines, a process for their preparation and their use as medicine App 20080039476 - Danysz; Wojciech ; et al.	2008-02-14
Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine App 20080039458 - Danysz; Wojciech ; et al.	2008-02-14
Pyrazolopyrimidines, a process for their preparation and their use as medicine App 20080032998 - Danysz; Wojciech ; et al.	2008-02-07
Metabotropic glutamate receptor modulators App 20070299113 - Kalvinsh; Ivars ; et al.	2007-12-27
Cyclic and acyclic propenones for treating CNS disorders App 20060074083 - Kalvinsh; Ivars ; et al.	2006-04-06
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors App 20060004001 - Jirgensons; Aigars ; et al.	2006-01-05
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors App 20050288284 - Jirgensons, Aigars ; et al.	2005-12-29
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors App 20050197361 - Jirgensons, Aigars ; et al.	2005-09-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.